A5009 - Laparoscopic sleeve gastrectomy after failed gastric banding: is it really effective?

Abstract

polycystic ovarian disease, pseudotumor cerebri, psychological impairment, alcohol use, substance abuse, tobacco use, and support group attendance did not vary by race. Conclusions: In the first 12 months after surgery, weight, weight loss, BMI and the resolution/persistence of weight-related comorbidities vary significantly by race among the mega-obese patients who choose to undergo Duodenal Switch. AfricanAmericans lost the most weight, but remained heavier than other racial groups, possibly related to higher pre-operative body mass. Nevertheless, African-Americans experienced the greatest resolution of seven obesity co-morbidities. Caucasians resolved hypertension well, but musculoskeletal and hepato-biliary conditions persisted. Hispanic patients benefited somewhat less from Duodenal Switch than did the other racial categories. The Other grouped nationalities benefited less for stress urinary incontinence, asthma, back pain and dyslipidemia, but did well with obesity-related liver disease. Whether or not these findings hold true for longer term outcomes after Duodenal Switch is not clear from the data and will require follow-up in larger populations of African-American and Hispanic patients. Knowing these racial variations in Duodenal Switch outcomes preoperatively may help to optimize the management of megaobese patients.